Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cogent Biosciences (COGT) Total Current Liabilities (2017 - 2021)

Cogent Biosciences (COGT) has 4 years of Total Current Liabilities data on record, last reported at $16.7 million in Q3 2021.

  • For Q3 2021, Total Current Liabilities fell 16.96% year-over-year to $16.7 million; the TTM value through Sep 2021 reached $16.7 million, down 16.96%, while the annual FY2020 figure was $13.1 million, 1.16% down from the prior year.
  • Total Current Liabilities reached $16.7 million in Q3 2021 per COGT's latest filing, up from $13.7 million in the prior quarter.
  • Across five years, Total Current Liabilities topped out at $26.4 million in Q3 2018 and bottomed at $8.2 million in Q1 2021.
  • Average Total Current Liabilities over 4 years is $18.5 million, with a median of $20.1 million recorded in 2020.
  • Peak YoY movement for Total Current Liabilities: tumbled 65.98% in 2020, then skyrocketed 65.45% in 2021.
  • A 4-year view of Total Current Liabilities shows it stood at $24.9 million in 2018, then plummeted by 46.89% to $13.2 million in 2019, then decreased by 1.16% to $13.1 million in 2020, then grew by 27.61% to $16.7 million in 2021.
  • Per Business Quant database, its latest 3 readings for Total Current Liabilities were $16.7 million in Q3 2021, $13.7 million in Q2 2021, and $8.2 million in Q1 2021.